Thomas Mather

Dr. Mather has over 35 years experience as an Oculoplastic surgeon. He graduated from Indiana University School of Medicine as an E.B. Rinker scholar, completed his Ophthalmology residency at Medical University of South Carolina, and his fellowship in Oculoplastic surgery at University of Arizona. He furthered his executive studies at Wharton School of Business. He is a life fellow of the American Academy of Ophthalmology and a fellow in the American Society of Ophthalmic Plastic and Reconstructive Surgeons (ASOPRS).

In 2004, Dr. Mather co-founded Physicians Eye Surgery Center in Charleston, SC, which was acquired by U.S. Eye in 2020.

Dr. Mather has been involved in several start up companies including Encore Pharmaceuticals, which provided a novel treatment of presbyopia, and was successfully purchased by Novartis (UNR 844) in 2017, Allysta Pharmaceuticals, a clinical stage company with significant advancements in both dry eye and NASH, where he currently serves as a clinical advisor, as well as Premark, a late stage Swiss company engaged in the treatment of blepharitis, where he serves as clinical advisor.

Dr. Mather has gained world recognition as a triathlete and runner with a marathon PR of 2:21, a U.S. national triathlon championship, and a top 100 finish in the Ironman World Championship triathlon in Hawaii.